Literature DB >> 19308961

A broad spectrum of developmental delay in a large cohort of prolidase deficiency patients demonstrates marked interfamilial and intrafamilial phenotypic variability.

Tzipora C Falik-Zaccai1, Morad Khayat, Anthony Luder, Pnina Frenkel, Daniella Magen, Riva Brik, Ruth Gershoni-Baruch, Hanna Mandel.   

Abstract

Prolidase deficiency (PD) is a rare, pan-ethnic, autosomal recessive disease with a broad phenotypic spectrum. Seventeen causative mutations in the PEPD gene have been reported worldwide. The purpose of this study is to characterize, clinically and molecularly, 20 prolidase deficient patients of Arab Moslem and Druze origin from 10 kindreds residing in northern Israel. All PD patients manifested developmental delay and facial dysmorphism. Typical PD dermatological symptoms, splenomegaly, and recurrent respiratory infections presented in varying degrees. Two patients had systemic lupus erythematosus (SLE), and one a novel cystic fibrosis phenotype. Direct DNA sequencing revealed two novel missense mutations, A212P and L368R. In addition, a previously reported S202F mutation was detected in 17 patients from seven Druze and three Arab Moslem kindreds. Patients homozygous for the S202F mutation manifest considerable interfamilial and intrafamilial phenotypic variability. The high prevalence of this mutation among Arab Moslems and Druze residing in northern Israel, and the presence of an identical haplotype along 500,000 bp in patients and their parents, suggests a founder event tracing back to before the breakaway of the Druze from mainstream Moslem society. (c) 2009 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 19308961     DOI: 10.1002/ajmg.b.30945

Source DB:  PubMed          Journal:  Am J Med Genet B Neuropsychiatr Genet        ISSN: 1552-4841            Impact factor:   3.568


  14 in total

1.  Serum prolidase activity in idiopathic and ischemic cardiomyopathy patients.

Authors:  Yusuf Sezen; Memduh Bas; Halil Altiparmak; Ali Yildiz; Hakan Buyukhatipoglu; Omer Faruk Dag; Zekeriya Kaya; Nurten Aksoy
Journal:  J Clin Lab Anal       Date:  2010       Impact factor: 2.352

2.  Prolidase deficiency breaks tolerance to lupus-associated antigens.

Authors:  Biji T Kurien; Anil D'Sousa; Benjamin F Bruner; Timothy Gross; Judith A James; Ira N Targoff; Jacen S Maier-Moore; Isaac T W Harley; Heng Wang; R Hal Scofield
Journal:  Int J Rheum Dis       Date:  2013-12-14       Impact factor: 2.454

Review 3.  The Role of Nucleic Acid Sensing in Controlling Microbial and Autoimmune Disorders.

Authors:  Keesha M Matz; R Marena Guzman; Alan G Goodman
Journal:  Int Rev Cell Mol Biol       Date:  2018-09-25       Impact factor: 6.813

4.  Flavivirus Antagonism of Type I Interferon Signaling Reveals Prolidase as a Regulator of IFNAR1 Surface Expression.

Authors:  Kirk J Lubick; Shelly J Robertson; Kristin L McNally; Brett A Freedman; Angela L Rasmussen; R Travis Taylor; Avram D Walts; Seitaro Tsuruda; Mizuki Sakai; Mariko Ishizuka; Elena F Boer; Erin C Foster; Abhilash I Chiramel; Conrad B Addison; Richard Green; Daniel L Kastner; Michael G Katze; Steven M Holland; Antonella Forlino; Alexandra F Freeman; Manfred Boehm; Kentaro Yoshii; Sonja M Best
Journal:  Cell Host Microbe       Date:  2015-07-08       Impact factor: 21.023

5.  Prolidase deficiency: it looks like systemic lupus erythematosus but it is not.

Authors:  Aharon Klar; Paulina Navon-Elkan; Alan Rubinow; David Branski; Haggit Hurvitz; Ernst Christensen; Morad Khayat; Tzipora C Falik-Zaccai
Journal:  Eur J Pediatr       Date:  2009-11-24       Impact factor: 3.183

6.  Prolidase directly binds and activates epidermal growth factor receptor and stimulates downstream signaling.

Authors:  Lu Yang; Yun Li; Yi Ding; Kyoung-Soo Choi; A Latif Kazim; Yuesheng Zhang
Journal:  J Biol Chem       Date:  2012-12-04       Impact factor: 5.157

7.  Prolidase Deficiency in a Mexican-American Patient Identified by Array CGH Reveals a Novel and the Largest PEPD Gene Deletion.

Authors:  Jonathan P Hintze; Amelia Kirby; Erin Torti; Jacqueline R Batanian
Journal:  Mol Syndromol       Date:  2016-04-14

8.  Prolidase deficiency associated with systemic lupus erythematosus (SLE): single site experience and literature review.

Authors:  Yonatan Butbul Aviel; Hana Mandel; Emily Avitan Hersh; Reuven Bergman; Orly Eshach Adiv; Anthony Luder; Riva Brik
Journal:  Pediatr Rheumatol Online J       Date:  2012-06-22       Impact factor: 3.054

9.  Quantitative analysis of the natural history of prolidase deficiency: description of 17 families and systematic review of published cases.

Authors:  Francis Rossignol; Marvid S Duarte Moreno; Carlos R Ferreira; Manuel Schiff; Jean-François Benoist; Manfred Boehm; Emmanuelle Bourrat; Aline Cano; Brigitte Chabrol; Claudine Cosson; José Luís Dapena Díaz; Arthur D'Harlingue; David Dimmock; Alexandra F Freeman; María Tallón García; Cheryl Garganta; Tobias Goerge; Sara S Halbach; Jan de Laffolie; Christina T Lam; Ludovic Martin; Esmeralda Martins; Andrea Meinhardt; Isabelle Melki; Amanda K Ombrello; Noémie Pérez; Dulce Quelhas; Anna Scott; Anne M Slavotinek; Ana Rita Soares; Sarah L Stein; Kira Süßmuth; Jenny Thies
Journal:  Genet Med       Date:  2021-05-26       Impact factor: 8.822

10.  Two novel mutations identified in familial cases with Donohue syndrome.

Authors:  Tzipora C Falik Zaccai; Limor Kalfon; Aharon Klar; Mordechai Ben Elisha; Haggit Hurvitz; Galina Weingarten; Emelia Chechik; Vered Fleisher Sheffer; Raid Haj Yahya; Gal Meidan; Eva Gross-Kieselstein; Dvora Bauman; Sylvia Hershkovitz; Yuval Yaron; Avi Orr-Urtreger; Efrat Wertheimer
Journal:  Mol Genet Genomic Med       Date:  2013-11-14       Impact factor: 2.183

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.